All Public Health articles – Page 9
-
NewsMeasles immunity 90% in BC’s Lower Mainland
In British Columbia’s Lower Mainland, 90% of people have detectable antibodies against measles, indicating high vaccine coverage and population protection, according to a new study.
-
NewsNew global burden of disease study: Mortality declines, youth deaths rise, widening health inequities
The world faces an emerging crisis of higher death rates in adolescents and young adults in North America and Latin America due to suicide and drug and alcohol consumption, and in sub-Saharan Africa due to infectious diseases and unintentional injuries.
-
NewsResearchers deconstruct chikungunya outbreaks to improve prediction and vaccine development
Researchers analyzed more than 80 outbreaks of chikungunya virus to improve prediction of future outbreaks and inform vaccine trial development.
-
NewsQdenga vaccine shows effectiveness against dengue under real-world conditions during Brazil’s 2024 outbreak
An international team of researchers has demonstrated that the tetravalent dengue vaccine Qdenga provides significant protection against the disease under real-world conditions, during the large 2024 epidemic in São Paulo, Brazil.
-
NewsScientist awarded $5 million to improve mental health and HIV care for adolescents in Uganda
The National Institutes of Health (NIH) has awarded Dr. Philip Kreniske $5,115,391 for a groundbreaking research project to improve mental health and antiretroviral treatment adherence among adolescents living with HIV in rural Uganda.
-
NewsUnder half in US would recommend some routine vaccinations during pregnancy
Data from a new APPC health survey finds a reluctance among the public to recommend that someone who is pregnant get a Covid-19 vaccine, with just 38% saying they would do so. Less than half of the survey respondents (42%) say it is safe to take an mRNA Covid-19 vaccine during pregnancy.
-
NewsStudy shows HPV vaccine protects vaccinated — and unvaccinated — women
A study has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from infections caused by the cervical-cancer-causing virus—including women who didn’t even receive the vaccine.
-
NewsDespite increase in U.S. cases, worry about West Nile virus remains low
Despite this season’s growing number of cases, relatively few Americans worry about becoming infected by West Nile or by dengue fever, another mosquito-borne illness, according to a survey of nearly 1,700 U.S. adults.
-
NewsVirologist leading team to bolster Canada’s ability to respond to future pandemics, public health emergencies
With $3M in new federal funding over two years, University of Ottawa Faculty of Medicine molecular virologist Dr. Marc-André Langlois and a multidisciplinary team of collaborators will be a vital part of Canada’s ability to respond effectively to infectious disease threats & future pandemics.
-
NewsMeta-analysis: COVID-19 vaccination during pregnancy is safe and beneficial for mother and infant
Vaccination is associated with better neonatal outcomes without added maternal risk, according to research presented during the American Academy of Pediatrics 2025 National Conference & Exhibition.
-
NewsStudy models how human behavior, lockdowns and restrictions shaped COVID’s spread
Researchers employed computer modeling and large datasets to better understand how COVID-19 was transmitted in one community in South Africa during the course of the worldwide pandemic.
-
NewsNew study finds dried blood spot test reliably detects congenital CMV at birth
New research confirms that testing for congenital cytomegalovirus (cCMV) at birth using the routinely collected dried blood spot (DBS) is a reliable and effective method to identify newborns at risk for long-term developmental challenges.
-
NewsMore than 50 scientific societies issue letter to Congress expressing concerns regarding executive order on federal grantmaking
A coalition of more than 50 scientific societies has issued a letter to the United States Congress, expressing concerns over provisions in the 7 August 2025 Executive Order (EO) titled “Improving Oversight of Federal Grantmaking.”
-
NewsCholera vaccination campaign launched in Darfur to protect over 1.8 million people
A cholera vaccination campaign kicked off on 21 September 2025 in South Darfur, marking the start of a campaign that aims to reach 1.86 million people aged one year and older with oral vaccines in response to the ongoing outbreak.
-
NewsTropical diseases: Global health meeting showcases resilience of field under fire
At a moment of monumental challenges for global health, thousands of researchers, clinicians and public health professionals from over 100 countries will gather in Toronto for the 2025 Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).
-
News'Know-do gap' drives inappropriate antibiotic overprescribing for child diarrhea in India
Researchers report that the persistent “know-do gap” — where clinicians know guidelines but practice differently — is the primary driver of antibiotic overprescribing for pediatric diarrhea in India’s private sector.
-
NewsStudy finds ticks carrying Lyme disease moving into western NC
A new surveillance study reveals that the primary vector of the bacteria that cause Lyme disease, the blacklegged tick, has been spreading into areas previously considered low risk.
-
NewsCan microbes be the good guys? New study reveals Hollywood’s blind spot
A new review shows how films — from French Kiss to The Martian — highlight microbes as allies in food, medicine, and even space exploration.
-
NewsScientists can decode wildlife movement to predict the next pandemic
By equipping wildlife with biologging devices that track movement and behavior in near-real-time, researchers can detect early signs of illness, monitor disease spread, and inform public health interventions before outbreaks reach crisis levels.
-
NewsMost Americans favor MMR vaccine requirement for public school, survey finds
Research in April 2025 finds that 70% of the US public supports vaccine requirements for MMR (measles, mumps, and rubella) for children to attend public school, more than in 2023.